Here, immunohistochemical analysis revealed that tumor tissues had higher CHK2 protein levels compared to the adjacent normal tissues, regardless of the CHEK2 mutation status of the patients, which appears to be a mechanism of the cells to signalize a defect in the DNA damage response pathway (56). Here, CHEK2 is linked to neoplasm.